Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

SHA:603896 Revenue

Zhejiang Shouxiangu Pharmaceutical had revenue of 104.85M CNY in the quarter ending September 30, 2026, a decrease of -19.63%. This brings the company's total for the last twelve months to 590.94M, down -9.93% year-over-year. In the year 2025, Zhejiang Shouxiangu Pharmaceutical had annual revenue of 640.18M, down -9.21%. That makes Zhejiang Shouxiangu Pharmaceutical the 23,616th largest company in the world by revenue and 4,265th in China.

• Revenue (ttm): 590.94M
• Revenue Growth: -9.93%
• P/S Ratio: 4.65
• Revenue / Employee: 528.09K
• Employees: 1,119
• Market Cap: 2.75B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Manufacturing 606.30M 96.5%
• Other 22.30M 3.5%

Fiscal year ended Dec 31, 2025 See the full SHA:603896 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	640.18M	-64.93M	-9.21%
Dec 31, 2024	705.11M	-79.24M	-10.10%
Dec 31, 2023	784.35M	-44.72M	-5.39%
Dec 31, 2022	829.07M	61.93M	8.07%
Dec 31, 2021	767.14M	131.09M	20.61%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error